results of a phase I clinical trial.
Melhem A, Stern M, Shibolet O
, Israeli E, Ackerman Z, Pappo O
, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y.
Liver Unit, Department of Medicine, Hebrew University, Hadassah Medical Center, Jerusalem, Israel.
BACKGROUND: The pathogenesis of chronic hepatitis C virus (HCV) infection is associated with a defective host antiviral immune response and intrahepatic oxidative stress.